Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40217
Submission : 2024-07-22
Status :
Type : IV
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38202
Submission : 2023-03-31
Status :
Type : IV
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
12
PharmaCompass offers a list of Salcaprozate Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Salcaprozate Sodium manufacturer or Salcaprozate Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Salcaprozate Sodium manufacturer or Salcaprozate Sodium supplier.
PharmaCompass also assists you with knowing the Salcaprozate Sodium API Price utilized in the formulation of products. Salcaprozate Sodium API Price is not always fixed or binding as the Salcaprozate Sodium Price is obtained through a variety of data sources. The Salcaprozate Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A sodium N-(8-(2-hydroxybenzoyl)amino)caprylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of sodium N-(8-(2-hydroxybenzoyl)amino)caprylate, including repackagers and relabelers. The FDA regulates sodium N-(8-(2-hydroxybenzoyl)amino)caprylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. sodium N-(8-(2-hydroxybenzoyl)amino)caprylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of sodium N-(8-(2-hydroxybenzoyl)amino)caprylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A sodium N-(8-(2-hydroxybenzoyl)amino)caprylate supplier is an individual or a company that provides sodium N-(8-(2-hydroxybenzoyl)amino)caprylate active pharmaceutical ingredient (API) or sodium N-(8-(2-hydroxybenzoyl)amino)caprylate finished formulations upon request. The sodium N-(8-(2-hydroxybenzoyl)amino)caprylate suppliers may include sodium N-(8-(2-hydroxybenzoyl)amino)caprylate API manufacturers, exporters, distributors and traders.
click here to find a list of sodium N-(8-(2-hydroxybenzoyl)amino)caprylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A sodium N-(8-(2-hydroxybenzoyl)amino)caprylate DMF (Drug Master File) is a document detailing the whole manufacturing process of sodium N-(8-(2-hydroxybenzoyl)amino)caprylate active pharmaceutical ingredient (API) in detail. Different forms of sodium N-(8-(2-hydroxybenzoyl)amino)caprylate DMFs exist exist since differing nations have different regulations, such as sodium N-(8-(2-hydroxybenzoyl)amino)caprylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A sodium N-(8-(2-hydroxybenzoyl)amino)caprylate DMF submitted to regulatory agencies in the US is known as a USDMF. sodium N-(8-(2-hydroxybenzoyl)amino)caprylate USDMF includes data on sodium N-(8-(2-hydroxybenzoyl)amino)caprylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The sodium N-(8-(2-hydroxybenzoyl)amino)caprylate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of sodium N-(8-(2-hydroxybenzoyl)amino)caprylate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing sodium N-(8-(2-hydroxybenzoyl)amino)caprylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for sodium N-(8-(2-hydroxybenzoyl)amino)caprylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture sodium N-(8-(2-hydroxybenzoyl)amino)caprylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain sodium N-(8-(2-hydroxybenzoyl)amino)caprylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a sodium N-(8-(2-hydroxybenzoyl)amino)caprylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of sodium N-(8-(2-hydroxybenzoyl)amino)caprylate suppliers with NDC on PharmaCompass.
sodium N-(8-(2-hydroxybenzoyl)amino)caprylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of sodium N-(8-(2-hydroxybenzoyl)amino)caprylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right sodium N-(8-(2-hydroxybenzoyl)amino)caprylate GMP manufacturer or sodium N-(8-(2-hydroxybenzoyl)amino)caprylate GMP API supplier for your needs.
A sodium N-(8-(2-hydroxybenzoyl)amino)caprylate CoA (Certificate of Analysis) is a formal document that attests to sodium N-(8-(2-hydroxybenzoyl)amino)caprylate's compliance with sodium N-(8-(2-hydroxybenzoyl)amino)caprylate specifications and serves as a tool for batch-level quality control.
sodium N-(8-(2-hydroxybenzoyl)amino)caprylate CoA mostly includes findings from lab analyses of a specific batch. For each sodium N-(8-(2-hydroxybenzoyl)amino)caprylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
sodium N-(8-(2-hydroxybenzoyl)amino)caprylate may be tested according to a variety of international standards, such as European Pharmacopoeia (sodium N-(8-(2-hydroxybenzoyl)amino)caprylate EP), sodium N-(8-(2-hydroxybenzoyl)amino)caprylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (sodium N-(8-(2-hydroxybenzoyl)amino)caprylate USP).
